Charles Schwab Investment Management Inc. Reduces Stock Position in PetMed Express, Inc. (NASDAQ:PETS)

Charles Schwab Investment Management Inc. cut its holdings in PetMed Express, Inc. (NASDAQ:PETS) by 46.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 109,186 shares of the company’s stock after selling 96,449 shares during the period. Charles Schwab Investment Management Inc. owned about 0.53% of PetMed Express worth $526,000 as of its most recent SEC filing.

Separately, R Squared Ltd acquired a new stake in shares of PetMed Express during the 4th quarter worth about $31,000. 73.33% of the stock is owned by institutional investors and hedge funds.

PetMed Express Price Performance

Shares of NASDAQ:PETS opened at $4.19 on Tuesday. PetMed Express, Inc. has a 12 month low of $2.90 and a 12 month high of $6.85. The firm has a market capitalization of $86.55 million, a P/E ratio of 419.42 and a beta of 0.78. The company’s fifty day moving average price is $4.46 and its 200 day moving average price is $4.54.

PetMed Express (NASDAQ:PETS) last posted its earnings results on Monday, February 10th. The company reported ($0.03) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.02). PetMed Express had a return on equity of 0.37% and a net margin of 0.14%. On average, sell-side analysts anticipate that PetMed Express, Inc. will post 0.19 EPS for the current year.

Analysts Set New Price Targets

Separately, StockNews.com downgraded PetMed Express from a “buy” rating to a “hold” rating in a report on Tuesday, February 11th.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.